Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.68 USD | -1.29% | -9.34% | -22.21% |
May. 14 | Transcript : Bioceres Crop Solutions Corp., Q3 2024 Earnings Call, May 14, 2024 | |
May. 14 | Bioceres Crop Solutions Fiscal Q3 Earnings, Revenue Fall | MT |
Valuation
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 191.4 | 218.9 | 567.2 | 565.2 | 839.3 | 671.2 | - | - |
Enterprise Value (EV) 1 | 191.4 | 218.9 | 567.2 | 565.2 | 839.3 | 671.2 | 881.2 | 671.2 |
P/E ratio | - | - | - | -80.6 x | 45 x | 33.4 x | 11.2 x | 7.49 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 1.19 x | 1.26 x | 2.71 x | 1.69 x | 2 x | 1.42 x | 1.17 x | 0.96 x |
EV / Revenue | 1.19 x | 1.26 x | 2.71 x | 1.69 x | 2 x | 1.42 x | 1.17 x | 0.96 x |
EV / EBITDA | - | 4.71 x | 11.7 x | 11 x | 10.3 x | 7.43 x | 5.83 x | 4.85 x |
EV / FCF | - | - | -39.1 x | -26.9 x | -95.7 x | 32.1 x | 10.2 x | 7.4 x |
FCF Yield | - | - | -2.56% | -3.71% | -1.05% | 3.11% | 9.8% | 13.5% |
Price to Book | - | - | - | - | 2.91 x | 2.07 x | 1.58 x | 1.29 x |
Nbr of stocks (in thousands) | 36,121 | 36,121 | 40,371 | 41,228 | 62,821 | 62,845 | - | - |
Reference price 2 | 5.300 | 6.060 | 14.05 | 13.71 | 13.36 | 10.68 | 10.68 | 10.68 |
Announcement Date | 9/13/19 | 9/10/20 | 9/9/21 | 9/8/22 | 9/11/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 160.6 | 173.1 | 209.5 | 334.8 | 419.8 | 473.2 | 574.4 | 701.4 |
EBITDA 1 | - | 46.5 | 48.3 | 51.5 | 81.1 | 90.28 | 115.1 | 138.3 |
EBIT 1 | - | 39.15 | 38.33 | 39.93 | 54.1 | 61.86 | 98.06 | 142.1 |
Operating Margin | - | 22.62% | 18.29% | 11.93% | 12.89% | 13.07% | 17.07% | 20.26% |
Earnings before Tax (EBT) 1 | - | - | - | 13.98 | 18.8 | 36.18 | 80.81 | 131 |
Net income 1 | - | - | - | -7.332 | 16.7 | 20.8 | 62.51 | 96.85 |
Net margin | - | - | - | -2.19% | 3.98% | 4.4% | 10.88% | 13.81% |
EPS 2 | - | - | - | -0.1702 | 0.2972 | 0.3200 | 0.9500 | 1.425 |
Free Cash Flow 1 | - | - | -14.52 | -20.97 | -8.772 | 20.9 | 65.8 | 90.7 |
FCF margin | - | - | -6.93% | -6.26% | -2.09% | 4.42% | 11.45% | 12.93% |
FCF Conversion (EBITDA) | - | - | - | - | - | 23.15% | 57.16% | 65.58% |
FCF Conversion (Net income) | - | - | - | - | - | 100.47% | 105.26% | 93.65% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 9/13/19 | 9/10/20 | 9/9/21 | 9/8/22 | 9/11/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 92.66 | 69.48 | 105.7 | 127.1 | 94.41 | 93.61 | 104.7 | 116.6 | 140.3 | 84 | 132.4 | 120 | 165 | 105 | 160 |
EBITDA 1 | 19.7 | 4.8 | 14.6 | 24.5 | 10.3 | 35.8 | 10.4 | 16.3 | 24.1 | 21.1 | 28.81 | - | - | - | - |
EBIT 1 | 17.7 | 2.147 | 10.04 | 16.99 | 2.219 | 29.87 | 5 | 5.3 | 16.8 | 13.2 | 22.54 | - | - | - | - |
Operating Margin | 19.1% | 3.09% | 9.5% | 13.37% | 2.35% | 31.91% | 4.78% | 4.55% | 11.97% | 15.71% | 17.03% | - | - | - | - |
Earnings before Tax (EBT) 1 | 9.48 | -2.637 | 2.273 | 8.666 | -7.745 | 22.29 | -4.6 | -2.2 | 9.6 | 8.8 | 16.78 | - | - | - | - |
Net income 1 | 3.427 | -6.487 | -5.147 | 0.4983 | -8.662 | 28.15 | -3.8 | -4.6 | 0.1 | 9.3 | 15.74 | - | - | - | - |
Net margin | 3.7% | -9.34% | -4.87% | 0.39% | -9.18% | 30.07% | -3.63% | -3.95% | 0.07% | 11.07% | 11.89% | - | - | - | - |
EPS 2 | 0.0808 | -0.1577 | -0.1171 | 0.008100 | -0.1381 | 0.4462 | -0.0611 | -0.0732 | 0.001560 | 0.1390 | 0.2400 | 0.0800 | 0.3400 | 0.0300 | 0.3600 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 2/10/22 | 5/12/22 | 9/8/22 | 11/10/22 | 2/9/23 | 5/10/23 | 9/11/23 | 11/13/23 | 2/8/24 | 5/13/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | 210 | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | 1.824 x | - |
Free Cash Flow 1 | - | - | -14.5 | -21 | -8.77 | 20.9 | 65.8 | 90.7 |
ROE (net income / shareholders' equity) | - | - | - | - | 7.84% | - | 2.3% | 2.3% |
ROA (Net income/ Total Assets) | - | - | - | - | 2.5% | 5.9% | 10.5% | 12.1% |
Assets 1 | - | - | - | - | 668.1 | 352.6 | 595.3 | 800.4 |
Book Value Per Share 2 | - | - | - | - | 4.590 | 5.150 | 6.740 | 8.270 |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | 2.81 | 3.46 | 11.4 | 12.2 | 4 | 4 |
Capex / Sales | - | - | 1.34% | 1.03% | 2.71% | 2.58% | 0.7% | 0.57% |
Announcement Date | 9/13/19 | 9/10/20 | 9/9/21 | 9/8/22 | 9/11/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.21% | 671M | |
+10.39% | 36.87B | |
-.--% | 11.53B | |
-10.13% | 7.07B | |
+3.68% | 6.61B | |
-4.35% | 5.92B | |
-5.87% | 5.65B | |
-0.38% | 5.42B | |
+36.15% | 5.38B | |
-6.16% | 4.85B |
- Stock Market
- Equities
- BIOX Stock
- Financials Bioceres Crop Solutions Corp.